e-learning
resources
Milan 2017
Sunday, 10.09.2017
Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC
R. de Vries (Amsterdam, Netherlands)
Source:
International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Session:
Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Session type:
Oral Presentation
Number:
1473
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. de Vries (Amsterdam, Netherlands). Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC. 1473
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients?
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
MDCT Parametric Response Mapping Identifies Loss of Lung Terminal Bronchioles in COPD
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference?
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Performance of Super ARMS to Detect EGFR Mutation Status in Plasma Cell-free DNA in Advanced Non-Small Cell Lung Cancer Patients
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Investigation of the Relationship Between Breath Retention Time and Blood Parameters in Stroke Patients
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020
Correlation of the Distance Saturation Product with spirometric and Diffusion Capacity for Carbon Monoxide data in patients with Interstitial Lung disease
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Late Breaking Abstract - Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
LATE-BREAKING ABSTRACT: Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in COPD?
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept